Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference390 articles.
1. Hormonal palliation of chemoresistant ovarian cancer: Three consecutive phase II trials of the Mid-Atlantic Oncology Program;Ahlgren;Journal of Clinical Oncology,1993
2. Genetic screen identifies insulin-like growth factor binding protein 5 as a Modulator of tamoxifen resistance in breast cancer;Ahn;Cancer Research,2010
3. Role of exogenous and endogenous hormones in endometrial cancer: Review of the evidence and research perspectives;Akhmedkhanov;Ann N Y Acad Sci,2001
4. Evidence for the metabolic activation of non-steroidal antioestrogens: A study of structure-activity relationships;Allen;British Journal of Pharmacology,1980
5. Estrogen receptor mutations and their role in breast cancer progression;Alluri;Breast Cancer Research,2014
Cited by 282 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis and in-silico Studies of 4-phenyl thiazol-2-amine Derivatives as Putative Anti-breast Cancer Agents;Current Computer-Aided Drug Design;2024-08
2. Aspirin as a potential drug repurposing candidate targeting estrogen receptor alpha in breast cancer: a molecular dynamics and in-vitro study;Journal of Biomolecular Structure and Dynamics;2024-01-27
3. Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy;Frontiers in Pharmacology;2024-01-24
4. Combining lapatinib and palbociclib inhibits cell proliferation and invasion via AKT signaling pathway in endocrine-resistant breast cancer cells;Medical Oncology;2024-01-17
5. Towards a New Generation of Hormone Therapies: Design, Synthesis and Biological Evaluation of Novel 1,2,3-Triazoles as Estrogen-Positive Breast Cancer Therapeutics and Non-Steroidal Aromatase Inhibitors;Pharmaceuticals;2024-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3